Similar articles

• Pharmacology of neuromuscular blocking agents in the intensive care unit.

  Hanson CW 3rd. Hanson CW 3rd. Crit Care Clin. 1994 Oct;10(4):779-97. Crit Care Clin. 1994. PMID: 8000926 Review.
• Complications involving neuromuscular pharmacology.

  Lebowitz PW, Savarese JJ. Lebowitz PW, et al. Int Anesthesiol Clin. 1980 Fall;18(3):139-56. doi: 10.1097/00004311-198001830-00012. Int Anesthesiol Clin. 1980. PMID: 6256298 Review. No abstract available.
• The neuromuscular blocking drugs.

  Torda TA. Torda TA. Med J Aust. 1988 Sep 19;149(6):316-9. doi: 10.5694/j.1326-5377.1988.tb120634.x. Med J Aust. 1988. PMID: 2843731 Review. No abstract available.
• Neuromuscular pharmacology. A clinical update and commentary.

  Lee C, Katz RL. Lee C, et al. Br J Anaesth. 1980 Feb;52(2):173-88. doi: 10.1093/bja/52.2.173. Br J Anaesth. 1980. PMID: 6244842 No abstract available.
• The priming principle revisited.

  Pearson KS, Gergis SD. Pearson KS, et al. Middle East J Anaesthesiol. 1992 Oct;11(6):555-62. Middle East J Anaesthesiol. 1992. PMID: 1336809 Review. No abstract available.